ASCENTAGE-B (06855) Announces February 2026 Monthly Return

Bulletin Express03-06

In February 2026, Ascentage Pharma Group International reported an authorized share capital of 500.00 million ordinary shares at a par value of USD 0.0001, totaling USD 50,000. The total number of issued shares stood at 373.32 million, with no changes from the preceding month. The company confirmed compliance with the 25% public float requirement.

Under its Pre-IPO Share Option Scheme, 2.15 million share options were outstanding, while the Post-IPO Share Option Scheme had 0.63 million share options outstanding. No new shares were issued or repurchased during the month, and no funds were raised through the exercise of share options. For the 2022 RSU Scheme, a maximum of 11.07 million shares may be granted, and 1.51 million remain issuable as of the end of February 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1124006260?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 06:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124006260","market":"hk","top_or_hot":-1,"title":"ASCENTAGE-B (06855) Announces February 2026 Monthly Return","media":"Bulletin Express","content":"<p>In February 2026, Ascentage Pharma Group International reported an authorized share capital of 500.00 million ordinary shares at a par value of USD 0.0001, totaling USD 50,000. The total number of issued shares stood at 373.32 million, with no changes from the preceding month. The company confirmed compliance with the 25% public float requirement.</p>\n<p>Under its Pre-IPO Share Option Scheme, 2.15 million share options were outstanding, while the Post-IPO Share Option Scheme had 0.63 million share options outstanding. No new shares were issued or repurchased during the month, and no funds were raised through the exercise of share options. For the 2022 RSU Scheme, a maximum of 11.07 million shares may be granted, and 1.51 million remain issuable as of the end of February 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ASCENTAGE-B (06855) Announces February 2026 Monthly Return</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nASCENTAGE-B (06855) Announces February 2026 Monthly Return\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-06 06:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>In February 2026, Ascentage Pharma Group International reported an authorized share capital of 500.00 million ordinary shares at a par value of USD 0.0001, totaling USD 50,000. The total number of issued shares stood at 373.32 million, with no changes from the preceding month. The company confirmed compliance with the 25% public float requirement.</p>\n<p>Under its Pre-IPO Share Option Scheme, 2.15 million share options were outstanding, while the Post-IPO Share Option Scheme had 0.63 million share options outstanding. No new shares were issued or repurchased during the month, and no funds were raised through the exercise of share options. For the 2022 RSU Scheme, a maximum of 11.07 million shares may be granted, and 1.51 million remain issuable as of the end of February 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06855","symbol_name":"亚盛医药-B","start_time":0,"source_url":"","article_id":"1124006260","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124006260","pubTimestamp":1772749722,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"In February 2026, Ascentage Pharma Group International reported an authorized share capital of 500.00 million ordinary shares at a par value of USD 0.0001, totaling USD 50,000. The total number of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06855":"亚盛医药-B"},"translate_title":"亚盛-B(06855)公布2026年2月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06855":1},"content_text":"In February 2026, Ascentage Pharma Group International reported an authorized share capital of 500.00 million ordinary shares at a par value of USD 0.0001, totaling USD 50,000. The total number of issued shares stood at 373.32 million, with no changes from the preceding month. The company confirmed compliance with the 25% public float requirement.\nUnder its Pre-IPO Share Option Scheme, 2.15 million share options were outstanding, while the Post-IPO Share Option Scheme had 0.63 million share options outstanding. No new shares were issued or repurchased during the month, and no funds were raised through the exercise of share options. For the 2022 RSU Scheme, a maximum of 11.07 million shares may be granted, and 1.51 million remain issuable as of the end of February 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1124006260","isCrawlerRequest":true}